Vaccination Undermined

For more than 200 years, vaccines have made an unparalleled contribution to public health. The writer and commentator Samuel Butler (1835-1902) wrote: "Vaccination is the medical sacrament corresponding to baptism." Considering the list of killer diseases that once held terror and are now under control, including polio, measles, diphtheria, pertussis, rubella, mumps, tetanus, and Haemophilus influenzae type b (Hib), one might expect vaccination to have achieved miracle status, not just sacrame

Written byRichard Gallagher
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For more than 200 years, vaccines have made an unparalleled contribution to public health. The writer and commentator Samuel Butler (1835-1902) wrote: "Vaccination is the medical sacrament corresponding to baptism." Considering the list of killer diseases that once held terror and are now under control, including polio, measles, diphtheria, pertussis, rubella, mumps, tetanus, and Haemophilus influenzae type b (Hib), one might expect vaccination to have achieved miracle status, not just sacramental.

Unfortunately, this could hardly be farther from the truth. Vaccines are unattractive targets for industry, underappreciated from the public health perspective, underfunded by basic research organizations, and treated with suspicion by the public. Multiple reasons exist for this, but the one that gets me steamed is the malign influence of three groups: antivaccine lobbyists, journalists, and lawyers.

The antivaccine lobby strikes me as ignorant. A simple Web search turns up numerous sites that are virulently antivaccination.1 Often these sites ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies